This result demonstrated that for patients with advanced digestive system cancer, in cases of anemia, low albumin and other chemotherapy complications were corrected, necessary neoadjuvant chemotherapy could shrink the tumor volume and reduce the difficulty of surgery and the risk of organ/space SSI. This evidence concerns the gene ALB and neoplasm.